PeptideDB

GLP-1 (9-36) amide (human, bovine, guinea pig, mouse, porcine, rat)

CAS No.: 161748-29-4

GLP-1 (9-36) amide also called Glucagon-Like Peptide 1 (9-36) amide, Preproglucagon (100-127) amide, Proglucagon (80-107
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

CAS 161748-29-4
Sequence H-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2
Sequence Single EGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2
Molecular Formula C140H214N36O43
Molecular Weight 3089.46
Synonyms Glucagon-Like Peptide 1 (9-36) amide (human, bovine, guinea pig, mouse, porcine, rat), Preproglucagon (100-127) amide (human, bovine, guinea pig, mouse, porcine, rat), Proglucagon (80-107) amide (human, bovine, guinea pig, mouse, porcine, rat)
Technology Synthetic
Storage -20°C, avoid light, cool and dry place
Application Diabetes
Description GLP-1 (9-36) amide also called Glucagon-Like Peptide 1 (9-36) amide, Preproglucagon (100-127) amide, Proglucagon (80-107) amide. Glucagon-like peptide-1 (GLP-1) is efficiently degraded by the enzyme dipeptidyl peptidase IV (DPP IV), yielding the major metabolite GLP-1 (9-36) amide. GLP-1 (9-36) amide does not affect glucose disposal in mice either in the presence or absence of intact GLP-1 receptors or in the presence or absence of stimulated insulin levels. This suggests that the GLP-1 metabolite is not involved in the regulation of glucose homeostasis. Elahi et al. have shown that this GLP-1 metabolite acts as a weak insulinotropic agent and inhibits hepatic glucose production.
References 1.  Differential activation of endopeptidase EC 3.4.24.15 toward natural and synthetic substrates by metal ions. A.J.Wolfson et al., Biochem. Biophys. Res. Commun., 229, 341 (1996) 2.  The major glucagon-like peptide-1 metabolite, GLP-1-(9-36)-amide, does not affect glucose or insulin levels in mice. B.Rolin et al., Eur. J. Pharmacol., 494, 283 (2004) 3.  Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes. B.Ahrén et al., Diabetes Care, 25, 869 (2002) 4.  GLP-1 (9-36) amide, cleavage product of GLP-1 (7-36) amide, is a glucoregulatory peptide. D.Elahi et al., Obesity, 16, 1501 (2008)